US 11786517
Methods of treatment using a JAK inhibitor compound
granted A61KA61K31/4545A61K9/0019
Quick answer
US patent 11786517 (Methods of treatment using a JAK inhibitor compound) held by Theravance Biopharma R&D IP, LLC expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4545, A61K9/0019, A61K9/0048, A61K9/0075